Abstract:Current risk stratification for stroke is still based upon percentage of carotid stenosis, despite this measure providing minimal patient-specific information on the actual risk of stroke for both symptomatic individuals without significant carotid artery stenosis as well as asymptomatic carotid stenosis patients. A continuously growing body of literature suggests that the identification and quantification of certain carotid plaque characteristics, including lipid-rich necrotic core (LRNC), thin/ruptured fibrous cap (FC), and intraplaque hemorrhage (IPH), provide a superior means of predicting future stroke. These characteristics are identifiable via magnetic resonance imaging (MRI), with most features detectable using commercially available coils and sequences utilized in routine clinical practice in as little as 4 minutes. The presence of LRNC, a thin/ruptured FC, and IPH is associated with increased risk of future stroke or TIA. Plaques with greater than 40% LRNC with a thin overlying FC are prone to rupture. LRNC is T2 hypointense and lacks enhancement on contrast enhanced T1 weighted images. Increasing LRNC size is associated with the development of new ulceration, FC rupture, increasing plaque burden, as well as fatal and nonfatal myocardial infarction, ischemic stroke, hospitalization for acute coronary syndrome (ACS), and symptom-driven revascularization, allowing for MR biomarkers of carotid plaque vulnerability to be utilized for systemic athero-thrombotic risk and not just stroke/TIA. LRNC typically shrinks with appropriate statin therapy, with PCSK9 inhibitors possibly playing a role in patients with inadequate response. Carotid plaques with IPH represent a more advanced stage of atherosclerotic disease. IPH is detectable with field strengths of both 3.0 T and 1.5 T and will demonstrate high signal on all T1 weighted imaging sequences. The presence of IPH increases the risk of future stroke in both symptomatic and asymptomatic patients, with multivariate analysis identifying IPH as a predictor of stroke, independent of percent stenosis, with no statistical difference in men vs. women, demonstrating that simple carotid stenosis measurements and traditional risk factor analysis may be inadequate in identifying patients at the highest risk for adverse cerebrovascular events. In the evaluation for recurrent stroke in recently symptomatic patients with >50% carotid stenosis, the estimated annual stroke risk is 23.2% in IPH+ patients and only 0.6% in IPH- patients, calling into question the current risk-benefit assessment for CEA. Additionally, a recent meta-analysis suggests that IPH+ plaque in patients with symptomatic <50% stenosis may be the etiology of embolic strokes previously labeled as "embolic stroke of undetermined source" (ESUS). There are no prospective drug trials testing the ability of any lipid-lowering therapies to decrease IPH and/or total plaque volume (TPV). Given the continuously increasing evidence of IPH as a significant predictor of carotid plaque progression and future adverse vascular events, trials aimed at targeted therapy for IPH represents a significant need.

Correlation Of Macrophage Location And Plaque Stress Distribution Using Uspio-Enhanced Mri In A Patient With Symptomatic Severe Carotid Stenosis: A New Insight Into Risk Stratification

Correlation Of Carotid Atheromatous Plaque Inflammation Using Uspio-Enhanced Mr Imaging With Degree Of Luminal Stenosis

Study of Carotid Arterial Plaque Stress for Symptomatic and Asymptomatic Patients.

Correlation of carotid atheromatous plaque inflammation with biomechanical stress: Utility of USPIO enhanced MR imaging and finite element analysis

Stress analysis of carotid plaque rupture based on in vivo high resolution MRI.

Utility of USPIO-enhanced MR Imaging to Identify Inflammation and the Fibrous Cap: a Comparison of Symptomatic and Asymptomatic Individuals.

Carotid Plaque Imaging and the Risk of Atherosclerotic Cardiovascular Disease

High-resolution magnetic resonance imaging of carotid atherosclerotic plaques - a correlation study with histopathology

MR imaging of vulnerable carotid plaque

Structural analysis and magnetic resonance imaging predict plaque vulnerability: a study comparing symptomatic and asymptomatic individuals.

Identifying Vulnerable Carotid Plaques in Vivo Using High Resolution Magnetic Resonance Imaging-Based Finite Element Analysis.

Stress Analysis of Carotid Plaque Based on in Vivo MRI of Acute Symptomatic and Asymptomatic Patients

Heavy macrophage infiltration identified by optical coherence tomography relates to plaque rupture

Association between biomechanical structural stresses of atherosclerotic carotid plaques and subsequent ischaemic cerebrovascular events--a longitudinal in vivo magnetic resonance imaging-based finite element study.

Non-invasive MR Imaging of Inflammation in a Patient with Both Asymptomatic Carotid Atheroma and an Abdominal Aortic Aneurysm: a Case Report

Discriminating Carotid Atherosclerotic Lesion Severity By Luminal Stenosis And Plaque Burden A Comparison Utilizing High-Resolution Magnetic Resonance Imaging At 3.0 Tesla

Association Between 18-FDG Positron Emission Tomography and MRI Biomarkers of Plaque Vulnerability in Patients With Symptomatic Carotid Stenosis

Normalized Wall Index Specific and MRI-based Stress Analysis of Atherosclerotic Carotid Plaques: a Study Comparing Acutely Symptomatic and Asymptomatic Patients.

Finite Element Analysis of Vulnerable Atherosclerotic Plaques: a Comparison of Mechanical Stresses Within Carotid Plaques of Acute and Recently Symptomatic Patients with Carotid Artery Disease.

Local Critical Stress Correlates Better Than Global Maximum Stress with Plaque Morphological Features Linked to Atherosclerotic Plaque Vulnerability: an in Vivo Multi-Patient Study

Characterisation of Carotid Atheroma in Symptomatic and Asymptomatic Patients Using High Resolution MRI.